Literature DB >> 22899605

New antiplasmodial bromotyrosine derivatives from Suberea ianthelliformis Lendenfeld, 1888.

Luke Mani1, Valerie Jullian, Beatrice Mourkazel, Alexis Valentin, Joëlle Dubois, Thierry Cresteil, Eric Folcher, John N A Hooper, Dirk Erpenbeck, William Aalbersberg, Cécile Debitus.   

Abstract

Four samples of Suberea ianthelliformis were investigated and furnished five new and 13 known brominated tyrosine-derived compounds. Two of the new compounds were identified as araplysillin N20-formamide and its N-oxide derivative. Three other new compounds, araplysillins IV, V, and VI, were isolated and identified as analogs of araplysillin II. Most of these compounds exhibit moderate inhibitory activities against chloroquine-resistant and -sensitive strains of Plasmodium falciparum, and were investigated for their PFTase inhibitory properties. The chemical content of the investigated sponges is correlated with their molecular phylogeny.
Copyright © 2012 Verlag Helvetica Chimica Acta AG, Zürich.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899605     DOI: 10.1002/cbdv.201100309

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  12 in total

1.  Bromotyrosine-derived metabolites from an Indonesian marine sponge in the family Aplysinellidae (Order Verongiida).

Authors:  Jingqiu Dai; Stephen M Parrish; Wesley Y Yoshida; M L Richard Yip; James Turkson; Michelle Kelly; Philip Williams
Journal:  Bioorg Med Chem Lett       Date:  2015-11-25       Impact factor: 2.823

Review 2.  Antiplasmodial natural products: an update.

Authors:  Nasir Tajuddeen; Fanie R Van Heerden
Journal:  Malar J       Date:  2019-12-05       Impact factor: 2.979

Review 3.  Cnidarians as a potential source of antiparasitic drugs.

Authors:  Osama Mostafa; Mohammed Al-Shehri; Mahmoud Moustafa; Ahmed Al-Emam
Journal:  Parasitol Res       Date:  2021-11-29       Impact factor: 2.289

Review 4.  Biological Activity of Recently Discovered Halogenated Marine Natural Products.

Authors:  Gordon W Gribble
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

5.  New antimicrobial bromotyrosine analogues from the sponge Pseudoceratina purpurea and its predator Tylodina corticalis.

Authors:  Michael P Gotsbacher; Peter Karuso
Journal:  Mar Drugs       Date:  2015-03-16       Impact factor: 5.118

6.  A modular synthesis of tetracyclic meroterpenoid antibiotics.

Authors:  Raphael Wildermuth; Klaus Speck; Franz-Lucas Haut; Peter Mayer; Bianka Karge; Mark Brönstrup; Thomas Magauer
Journal:  Nat Commun       Date:  2017-12-12       Impact factor: 14.919

7.  Bioactive Bromotyrosine-Derived Alkaloids from the Polynesian Sponge Suberea ianthelliformis.

Authors:  Amr El-Demerdash; Céline Moriou; Jordan Toullec; Marc Besson; Stéphanie Soulet; Nelly Schmitt; Sylvain Petek; David Lecchini; Cécile Debitus; Ali Al-Mourabit
Journal:  Mar Drugs       Date:  2018-04-27       Impact factor: 5.118

Review 8.  Marine Pharmacology in 2012-2013: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2017-08-29       Impact factor: 5.118

9.  Quorum Sensing Inhibitory and Antifouling Activities of New Bromotyrosine Metabolites from the Polynesian Sponge Pseudoceratina n. sp.

Authors:  Florent Tintillier; Céline Moriou; Sylvain Petek; Marilyne Fauchon; Claire Hellio; Denis Saulnier; Merrick Ekins; John N A Hooper; Ali Al-Mourabit; Cécile Debitus
Journal:  Mar Drugs       Date:  2020-05-21       Impact factor: 5.118

10.  Anti-Tumor Activity vs. Normal Cell Toxicity: Therapeutic Potential of the Bromotyrosines Aerothionin and Homoaerothionin In Vitro.

Authors:  Antje Drechsel; Jana Helm; Hermann Ehrlich; Snezana Pantovic; Stefan R Bornstein; Nicole Bechmann
Journal:  Mar Drugs       Date:  2020-05-01       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.